1. Introduction
===============

Langerin (CD207) is a C-type lectin expressed in human exclusively by Langerhans cells (LCs), which constitute a subset of dendritic cells that are located in epithelium of mucosal tissues and epidermis ([@bib15; @bib28]). LCs play a key role in the induction of immune responses against invading pathogens by capturing and processing foreign antigens and migrating to draining lymph nodes to present processed antigens to T cells ([@bib3]). As a C-type lectin, Langerin is thought to play a role in pathogen recognition by facilitating pathogen uptake and processing for antigen presentation ([@bib20]). Langerin is a type II transmembrane protein that contains one calcium-dependent carbohydrate recognition domain with a short cytoplasmic tail with a proline rich motif ([@bib36]). Langerin forms a trimer on the cell surface and upon crosslinking with either a cell-bound or a soluble ligand, Langerin induces the formation of Birbeck granules, which are LC-specific intracellular organelles that appear as tennis-racket like structures with a size of \<1 μm in diameter that are thought to be part of the endosomal recycling pathway ([@bib35]).

Although Langerin is characterized as a pathogen recognition receptor, only few pathogens have been demonstrated to interact with Langerin. Both HIV-1 ([@bib13; @bib34]) and *Mycobacteria leprae* ([@bib20]) have been identified as pathogens that interact with human Langerin, whereas murine Langerin was shown to bind to *Candida albicans* ([@bib32; @bib33]). Langerin is important in protecting against HIV-1 transmission, since HIV-1 captured by Langerin is rapidly internalized into Birbeck granules for degradation, thereby preventing HIV-1 infection of LCs ([@bib13; @bib34]). Based on the carbohydrate recognition specificity for mannose, fucose and N-acetyl-glucosamine monosaccharides (GlcNAc) ([@bib31]), it is likely that Langerin has a broader specificity for pathogens than has been identified so far.

Fungal species are ubiquitous residents of human skin and many can cause invasive infections especially in immuno-compromised individuals. They can be acquired from the environment, such as *Cryptococcus neoformans*, or are part of the normal skin microbiota, such as *Candida albicans* ([@bib29]) or *Malassezia* species ([@bib4; @bib19]). The close contact of the fungi with the epidermis and epithelial barrier suggests that LCs might be involved in fungal defense. Therefore we have investigated the interaction of a panel of fungi with Langerin on LCs.

Fungi, such as *Candida* species ubiquitously express β-glucans and mannosylated carbohydrate structures in their cell wall ([@bib11; @bib16]). Here we demonstrate that Langerin not only recognizes mannose, fucose and GlcNAc structures, but also β-glucan structures. To our knowledge, thus far dectin-1 is the only C-type lectin in human that has been associated with β-glucan binding ([@bib9; @bib8]). Here, we demonstrate that aside from dectin-1, Langerin also interacts with β-glucans, which can possibly mediate recognition of fungi and bacteria to initiate an anti-microbial response.

In addition, we demonstrate that Langerin is a receptor for *Candida* species, *Saccharomyces* species and *Malassezia furfur*, but only weakly interacts with *Cryptococcus gattii* and *Cryptococcus neoformans*. Our data further show that Langerin is the main C-type lectin receptor for fungi on primary human LCs even though these also express dectin-1. Thus, we have demonstrated that Langerin on LCs is a pathogen recognition receptor for β-glucans and a broad range of fungi. Increased knowledge of the pathogen recognition profile by Langerin on LCs can contribute to the understanding of the pathogenicity of fungi.

2. Results
==========

2.1. Langerin recognizes *Candida*, *Malassezia* and *Saccharomyces* species
----------------------------------------------------------------------------

A large panel of pathogenic fungi was screened for binding to recombinant Langerin in an ELISA system ([Table 1](#tbl1){ref-type="table"}). This recombinant Langerin contains the whole extracellular region including the carbohydrate recognition domain and the coiled--coil stalk that allows oligomerization ([@bib31]). To determine the specificity of the binding, polysaccharide mannan was used to inhibit the C-type lectin domain. Langerin interacted strongly with all *Saccharomyces* species, *Malassezia furfur* and *Candida* species, including *C. albicans*, *C. dubliensis*, *C. glabrata*, *C. guilliermondii*, *C. krusei*, *C. parapsilosis*, *C. tropicalis*, *C. lusitaniae*, *C. nivariensis*, *C. orthopsilosis* and *C. metapsilosis* ([Fig. 1](#fig1){ref-type="fig"}A and B). In contrast, no or low binding was observed for *Cr. neoformans* varieties and *Cr. gattii* of different serotypes ([Fig. 1](#fig1){ref-type="fig"}B). The inclusion of an acapsular *Cr. neoformans* (CBS 7935) demonstrated that the lack of binding is not due to the capsule.

To investigate the interaction between these fungi and Langerin in depth, a selection was made and a titration was performed. To determine the specificity of the Langerin binding ELISA, we investigated the ability of mannan and anti-Langerin to block the interaction of Langerin with coated ligands. Both inhibitors prevented Langerin binding to different concentrations of mannan and *C. albicans*, although mannan is slightly more efficient in blocking Langerin compared to anti-Langerin ([Fig. 1](#fig1){ref-type="fig"}C and D). In addition, both life and heat-killed *C. albicans* were compared and similar binding patterns were observed, demonstrating that heat-treatment did not alter the binding to Langerin ([Fig. 1](#fig1){ref-type="fig"}E).

Langerin efficiently interacted with all *Candida* species tested, namely *C. albicans*, *C. glabrata*, *C. guilliermondii*, *C. krusei*, *C. lusitaniae*, and *C. nivariensis*, and *Saccharomyces cerevisiae* at a concentration of 10^6^ and 10^7^/ml, whereas most binding was lost at 10^5^/ml or lower ([Figs. 1D and 2A, B and E](#fig1 fig2){ref-type="fig"}). No difference was observed between virulent and non-virulent strains of *S. cerevisiae* ([Fig. 2](#fig2){ref-type="fig"}E). *Cryptococcus* species only weakly interacted with Langerin at high concentrations which was abrogated after dilution ([Fig. 2](#fig2){ref-type="fig"}C and D). These data demonstrate that Langerin is a fungal receptor that interacts with *Malassezia furfur*, *Saccharomyces* and *Candida* species but not with *Cryptococcus* species.

2.2. Langerin binds to β-glucans
--------------------------------

Langerin has been shown to interact strongly with mannose, fucose and GlcNAc structures ([Fig. 3](#fig3){ref-type="fig"}A) ([@bib31]). In addition, Langerin interacts with both Lewis B and Lewis Y through terminal fucose structures, whereas it does not interact with internal fucose present in Lewis A and Lewis X ([@bib12]). In general, fungal cell walls contain a large amount of mannose structures, chitin, as well as β(1--3) and β(1--6)-glucans at the inner-layer and budding scars ([@bib11]). Mannan is a major component of the mannose structures on the cell wall and also a well-known ligand for Langerin ([@bib31; @bib11]). Therefore we investigated whether Langerin also interacts with other fungal-derived structures. Strikingly, Langerin strongly interacted with curdlan, laminarin and zymosan ([Fig. 3](#fig3){ref-type="fig"}B) and this binding was inhibited by both mannan and laminarin (3C--F). Both curdlan and laminarin contain large amount of β-glucans, while zymosan is a ghost cell derivative of *S. cerevisiae*, containing both mannose and β-glucans. It has previously been demonstrated that β-glucans partially inhibit zymosan binding to mouse Langerin, which suggests a role for Langerin in β-glucan binding ([@bib33]). Here, we demonstrate that Langerin directly interacts with β-glucans. These data demonstrate that Langerin recognizes also β-glucans, which could facilitate recognition of fungi.

2.3. Cellular Langerin interacts with *Candida* species and Zymosan but not with *Cryptococcus* species
-------------------------------------------------------------------------------------------------------

Next, we investigated whether a selection of this panel also interacted with cellular Langerin. Fluorescently labelled *C. albicans*, *C. krusei*, *Cr. neoformans*, *Cr. gattii*, and zymosan were incubated with a Langerin transduced cell-line, or a mock transduced cell-line. We selected the Jurkat T cell cell-line since it does not express dectin-1, which has been identified as a primary receptor for β-glucans ([Fig. 4](#fig4){ref-type="fig"}A). *C. albicans*, *C. krusei* and zymosan strongly interacted with Langerin transduced cells, which was completely inhibited by mannan, whereas no binding was observed to mock-transduced cells ([Fig. 4](#fig4){ref-type="fig"}B). In concordance with the Langerin binding ELISA, *Cr. neoformans* and *Cr. gattii* did neither interact with the Langerin transduced cells, nor with the mock-transduced cells. These data strongly suggest that Langerin recognizes *Candida* species but not *Cryptococcus* species.

2.4. Langerin is the primary receptor for fungi on primary Langerhans cells
---------------------------------------------------------------------------

Opportunistic fungal infections often enter through the skin or mucosal tissues, where LCs are the predominant antigen presenting cells. Therefore, we investigated whether primary human LCs interact with different fungi. CD1a^+^ LCs isolated from human epidermis express high levels of Langerin, low levels of dectin-1 and no DC-SIGN ([Fig. 5](#fig5){ref-type="fig"}A). Both DC-SIGN and dectin-1 have been shown to bind fungi through mannan and β-glucan structures, respectively ([@bib10; @bib9]). Primary LCs were incubated with fluorescently labelled *C. albicans*, *C. krusei*, *Cr. neoformans*, *Cr. gattii*, and zymosan and binding was measured by flow cytometry. Strikingly, LCs strongly interacted with *C. albicans*, *C. krusei*, and zymosan, but not with *Cr. neoformans* or *Cr. gattii* ([Fig. 5](#fig5){ref-type="fig"}B). The binding to *C. albicans*, *C. krusei*, and zymosan was primarily mediated via Langerin, since both mannan and specific antibodies against Langerin inhibited the binding to LCs ([Fig. 5](#fig5){ref-type="fig"}B). The blocking antibody against dectin-1 only weakly interfered with fungi binding to LCs, strongly suggesting that the contribution of dectin-1 on LCs is minor. *Cr. neoformans* and *Cr. gattii* failed to interact with LCs even at very high concentrations (data not shown). We observed a background binding of approximately 10%, which could be due to other receptors, such as complement receptor 3 expressed in low levels by LCs ([@bib14; @bib25]).

Next, we have used electron microscopy to investigate the uptake of *C. albicans* by LCs. LCs are able to phagocytose *C. albicans* ([Fig. 6](#fig6){ref-type="fig"}A), but we also observed *C. albicans* at the cell surface ([Fig. 6](#fig6){ref-type="fig"}). Notably, Langerin was regularly localized at the interface of the cell surface and *C. albicans*, either when phagocytosed or cell-bound ([Fig. 6](#fig6){ref-type="fig"}B--D). Irregular and detached cell wall was due to the EM preparation procedure. Thus, on LCs Langerin is the primary receptor for fungi such as *C. albicans* and the interaction can lead to phagocytosis of the fungi particles.

3. Discussion
=============

Opportunistic fungal infections are a well-known problem, especially in immuno-compromised patients, such as HIV-1 infected people and transplantation patients. With an increase in the survival of these patients, there is also an increasingly large number of patients that suffer from opportunistic fungal infections ([@bib23]). *Candida* species, especially *C. albicans*, and *Cryptococcus* species are the most common causes of invasive fungal infections in immuno-compromised patients ([@bib26; @bib27]). These fungi can colonize the skin and mucosal tissues that contain LCs and this dendritic cell subset might be crucial in the defense against fungi.

Our data show that Langerin is the major receptor on primary LCs for *Candida* species, *Saccharomyces* species, and *Malassezia furfur*. Notably, we did not observe any interaction of LCs with *Cryptococcus* species, suggesting that this pathogenic fungus is evading immune recognition by LCs.

Although *C. albicans* is still the leading cause of candidiasis, infections with variants such as *C. parapsilosis* and *C. glabrata* are increasingly common ([@bib1; @bib2]). The cell wall of *Candida* species consists of mannose structures (mannan), chitins (GlcNAc structures) and β-1,3- and β-1,6-glucose polymers (β-glucans). The mannan components are present on the outer cell layer, whereas chitins and β-glucans are the structural components of the wall and exposed at budding scars ([@bib21]). The C-type lectins dectin-1 and DC-SIGN are known fungal receptors that recognize fungi through β-glucan and mannan structures, respectively ([@bib10]). Here we demonstrate that Langerin is also a fungal receptor that interacts with a large variety of *Candida* species including *C. albicans*, *C. parapsilosis*, *C. glabrata*, *C. krusei*, *C. nivariensis*, *C. lusitaniae* and more. This suggests that *Candida* species express conserved structures that interact with Langerin. Strikingly, we observed that Langerin does not only recognizes mannose structures on fungi but also β1,3-glucan structures. Currently, dectin-1 is the main C-type lectin that specifically interacts with β-glucans and interaction of dectin-1 on macrophages and dendritic cells with *C. albicans* can modulate immune responses ([@bib7]). Here, we demonstrate that Langerin also has affinity for β-glucans and that on human primary LCs, Langerin accounts for the majority of the interaction of *Candida* species. Together these data show that Langerin shares carbohydrate specificities with both DC-SIGN and dectin-1 ([@bib37; @bib7]).

The signalling pathways for dectin-1 and DC-SIGN have been largely identified and dectin-1 plays a central role in the defense against fungal infections ([@bib7; @bib17]). Since dectin-1 appears to play a minor role in the binding of *C. albicans* to LCs, and Langerin interaction is more prominent, it is of great interest to investigate the immunological consequences of Langerin binding to fungi. Using electron microscopy we observed co-localization of Langerin with *C. albicans*. We have previously demonstrated that interaction of viruses such as HIV-1 and Langerin can lead to internalization in Langerin positive Birbeck granules ([@bib13]). Due to the large size of *C. albicans* it seems unlikely that *C. albicans* can be internalized efficiently into Birbeck granules. However, our data demonstrate that LCs phagocytose fungi albeit not very efficiently. Questions remain whether Langerin is able to capture and degrade fungal pathogens in a similar manner as it is capable of degrading HIV-1. Noteworthy, we did observe that *C. albicans* but not *Cryptococcus* species could prevent the binding of HIV-1 to Langerin (data not shown), suggesting this could interfere with the protective barrier provides by Langerin on LCs and facilitate HIV-1 infection of LCs ([@bib13]). However, this remains to be further determined.

*S. cerevisiae* is one of the most well-studied yeast and shows high similarity to *C. albicans*' cell-wall architecture ([@bib21]). Indeed, similar to *C. albicans*, *S. cerevisiae* strongly interacted with Langerin. In addition, we observed comparable binding the non-virulent genome-sequenced strain of *S. cerevisiae* and a virulent strain. These data suggest that Langerin binding does not account for the differences in virulence.

*Malassezia* species are present as normal skin flora, however they are also associated with several skin diseases such as seborrehic dermatisis, atopic dermatitis, pityriasis versicolor and Malassezia folliculitis ([@bib4; @bib19]). Most *Malassezia* species are lipid dependent ([@bib39]), while one species, *M. pachydermatis*, is lipophilic and their cell wall is relatively thick ([@bib24]). Recently, it was demonstrated that *Malassezia* species have low mannose content in the cell wall, but strikingly *Malassezia* species reacted with anti-β-1,3-glucan antibody ([@bib30]). Here, we demonstrate that Langerin interacts with *M. furfur* and this suggests that the interaction is mediated via β-glucan structures. *M. furfur* and *M. pachydermatis* recently been identified as an activating ligand for C-type lectin Mincle ([@bib40]). Notably, we did not observe binding of Langerin to *M. pachydermatis* (data not shown). No difference in galactomannan spectra was observed by [@bib30], however *M. pachydermatis* is a single non-lipid dependent species, which might account for the difference in binding to Langerin because of differences in cell-wall composition.

*Cryptococcus* species *Cr. neoformans*, which has a predilection for the central nervous system and is highly prevalent in HIV-1 infected patients, and *Cr. gattii*, which can cause infections in immune-competent patients, did not interact with Langerin. Although it has been described that the capsule of *Cr. neoformans* determines its virulence and allows immune escape by circumventing recognition by antigen presenting cells ([@bib38; @bib22]), binding by Langerin was not rescued using an acapsular variant. These data suggest that underneath the capsule, no carbohydrate structures are present that are recognized by Langerin. It remains to be determined whether acapsular *Cr. neoformans* can elicit proper immune response in LCs.

In this screening of opportunistic and pathogenic fungi interaction with Langerin and LCs we demonstrate that Langerin is a receptor for *Candida* species, *Saccharomyces* species and *Malassezia furfur* and we have shown that Langerin is a β-glucan receptor. This knowledge strongly suggests that Langerin is an important fungal receptor on LCs. It remains to be determined whether the binding is mediated via mannose structures or β-glucans present on fungi. Moreover, future studies are necessary to further examine the immunological consequences of these fungal interactions with Langerin on LCs and how this can contribute to the pathogenicity of fungal infections.

4. Materials and methods
========================

4.1. Antibodies and reagents
----------------------------

The following antibodies and reagents were used: CD1a-FITC, Langerin-PE, DCGM4 (anti-Langerin) (all Immunotech), goat anti-mouse-FITC (Zymed Laboratories Inc.), isotype control IgG1 and IgG2b, anti dectin-1 (259931), and polyclonal anti-Langerin (all R&D systems), AZN-D1 (anti-DC-SIGN) ([@bib18]), 10E2 (anti-Langerin) ([@bib13]). Mannan from *S. cerevisiae*, curdlan from *Alcaligenes faecalis*, laminarin from *Laminaria digitata*, zymosan from *S. cerevisiae* (all Sigma--Aldrich), and zymosan-FITC (Molecular probes). Biotinylated polyacrylamide (PAA)-coupled glycoconjucates Mannose, Fucose, GlcNAc (N-acetyl-glucoseamine), GalNAc (N-acetyl-galactoseamine), Lewis (Le)X (Galβ1-4(Fucα1-3)GlcNAc), LeY (Fucα1-2Galβ1-4(Fucα1-3)GlcNAc), LeA (Galβ1-4(Fucα1-3)GlcNAc), LeB (Fucα1-2Galβ1-4(Fucα1-3)GlcNAc) were obtained from Lectinity. The following buffers were used: TSM buffer: Tris buffer (20 mM Tris--HCl, pH 7, 150 mM NaCl, 1 mM CaCl~2~, 2 mM MgCl~2~) (TSM), TSA buffer: TSM supplemented with BSA. PBA buffer: PBS supplemented with 0.5% BSA and 0.02% Azide.

4.2. Yeast preparation
----------------------

Yeast strains were obtained from CBS Fungal Biodiversity Centre ([www.cbs.knaw.nl](http://www.cbs.knaw.nl/)) and included some new hybrid strains ([@bib5; @bib6]). Yeast strains were cultured for 3 days at 25 °C on YPGA medium followed by inoculation in Sabouraud dextrose broth and incubated at 25 °C for 3 days, while shaking.

*Malassezia* strains were cultured on solid mLNA medium for 3 days at 30 °C. Yeast strains were harvested and heat inactivated for 1 h at 56 °C. Optical density measurement at 600 nm was used to determine the concentration. Yeast strains were washed extensively in PBS before storage at −20 °C at a concentration of 5 × 10^8^/ml until use.

4.3. Cell-lines and LC isolation
--------------------------------

Jurkat and Jurkat-Langerin transduced cells were produced as described previously and were cultured in RPMI medium with 10% FCS ([@bib35; @bib13]).

To isolate human LCs, human tissue was obtained from healthy donors undergoing corrective breast or abdominal surgery after informed consent in accordance with institutional guidelines and used within 3 h after surgery. The skin is cut in 0.3 mm slices containing the dermis and epidermis and incubated overnight at 4 °C in dispase II (1 mg/ml, Roche diagnostics) in Iscoves Modified Dulbecco\'s medium (IMDM) and gentamycin (10 μg/ml) overnight. The epidermis was mechanically separated and cultured in IMDM, 10% FCS, gentamycin (10 μg/ml), GM-CSF (800 U/ml) and IL-4 (800 U/ml). After 3 days the cells were harvested and layered on a ficoll density gradient to obtaining a 90% pure LC population as determined by flow cytometry and used immediately ([@bib13]).

4.4. Langerin binding ELISA
---------------------------

Different fungi (10^4^--10^7^/ml), carbohydrate structures (2 μg/ml) or β-glucans were coated onto ELISA plates overnight at room temperature. Non-specific binding was blocked by incubating the plate with 2% TSA buffer for 1 h at 37 °C. Recombinant human Langerin ([@bib31]) (2 μg/ml in 2% TSA) was added for 1 h at 37 °C. Unbound Langerin was washed away and binding was determined using an anti-Langerin antibody (DCGM4, Beckman Coulter Inc.) followed by peroxidise-conjugated goat anti-mouse IgG antibody (Jackson Immunoresearch). Specificity was determined in the presence of mannan (1 mg/ml) or anti-Langerin monoclonal antibody 10E2 (10 μg/ml) ([@bib13]). Efficient coating of the different fungi was confirmed with plant-lectin binding ConA (*Canavalia ensiformis*).

4.5. Facs analysis
------------------

50,000 cells (Jurkat, Jurkat-Langerin or LCs) were washed in PBA and incubated with specific antibodies (5 μg/ml) or isotype controls for 30 min at 4 °C and followed by an incubation with FITC-labelled secondary antibodies for 30 min at 4 °C, or cells were incubated with directly labelled antibodies for 30 min at 4 °C. Cells were washed and binding was measured using flow cytometry.

4.6. Fitc labelling
-------------------

Yeast strains were incubated with Fluorescein, 5′-isothiocyanate isomer I (FITC) (Sigma) (1 mg/ml in DMSO) for 1 h at room temperature. Yeast strains were washed extensively in PBS to eliminate unbound FITC. The solution was resuspended at a concentration of 1 × 10^8^/ml and stored at 4 °C in the dark until use.

4.7. Cell binding assay
-----------------------

50,000 cells (Jurkat, Jurkat-Langerin or LCs) were washed in 0.5% TSA and pre-incubated with mannan, blocking antibodies against Langerin or dectin-1, or isotype controls for 15 min at 37 °C. Different strains of FITC-labelled yeast were added for 45 min at 37 °C. Cells were washed and binding was measured using flow cytometry. Forward-site scatter gating was used to exclude unbound yeast.

4.8. Electron microscopy
------------------------

LCs (1 × 10^6^) were incubated with 1 × 10^7^ *C. albicans* for 4 h. Cells were fixed and sections were prepared according to standard protocol ([@bib13]). Sections were stained for Langerin as described previously using polyclonal Langerin antibody (R&D) ([@bib13]).
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![Langerin recognizes *Candida* species, *M*. *furfur* and *Saccharomyces* species. (A and B) Yeast strains were coated onto ELISA plates (10^7^/ml) and binding to recombinant Langerin was determined. Polysaccharide mannan was used to determine the specificity of the binding. (C and D) Polysaccharide mannan (C) and *C. albicans* (D) were coated onto ELISA plates at different concentrations. Both mannan and blocking antibody against Langerin (10E2) ([@bib13]) were used to determine specificity. (E) Binding of life and heat-treated *C. albicans* to Langerin. Data represent results from at least three independently performed ELISAs and was performed with two different batches of yeast strains. Error bars represent standard deviation of triplicates.](gr1){#fig1}

![Titration of a selection of fungi. Yeast strains from *Candida* species (A and B), *Cryptococcus neoformans* (C), *Cryptococcus gattii* (D), and *Saccharomyces cerevisiae* (E) were coated onto ELISA plates at different concentrations. Mannan was used to determine specificity. Data are representative of at least three independent experiments. Error bars represent standard deviation of triplicates.](gr2){#fig2}

![Langerin is a receptor for β-glucans. (A) Langerin specifically interacts with mannose, fucose and GlcNAc structures. Carbohydrate binding to Langerin was determined by recombinant Langerin ELISA. Specificity was determined by mannan, anti-Langerin (10E2) ([@bib13]) or isotype control antibodies. (B--F) Langerin is a receptor for β-glucans present on curdlan, laminarin and zymosan. Mannan (C), zymosan (D), laminarin (E) and curdlan (F) were coated onto ELISA plates in different concentrations. Binding to Langerin was inhibited by addition of mannan or laminarin. Data represent results from at least three independent experiments. Error bars represent standard deviation of triplicates.](gr3){#fig3}

![*Candida* species and zymosan interact with cellular Langerin. (A) Langerin and dectin-1 expression on Jurkat cell-line transduced with Langerin. Thin line represents isotype control, filled histogram represents specific staining. (B) Langerin expressing cell-line was incubated with different concentrations of FITC-labelled fungi and binding was measured by flow-cytometric analysis. Pre-incubation with mannan was used to determine specificity. Data represent results from at least three independent experiments. Error bars represent standard deviation of triplicates.](gr4){#fig4}

![Langerin is the primary receptor for fungi on LCs. (A) CD1a, Langerin, dectin-1 and DC-SIGN expression on primary immature LCs. Thin line represents isotype control, filled histogram represents specific staining. (B) Binding of different fungi to human LCs was investigated. FITC-labelled fungi were incubated with LCs at MOI 10. Specificity was determined by mannan, blocking antibodies against Langerin and dectin-1, or isotype controls. Binding was measured by flow cytometry. Data represent results from at least three different donors. Error bars represent standard deviation of triplicates.](gr5){#fig5}

![Electron microscopic analysis of *Candida albicans* interaction with LCs. (A) Electron microscopic picture of LCs which has internalized *C. albicans* (C). Arrow is directed towards *C. albicans*. (B--D) Gold labelling of Langerin demonstrates Langerin localization at the binding site of LCs and *C. albicans*. Arrows are directed towards Langerin gold labelling. Picture (B) is a magnification of (A), and (D) is a magnification of (C).](gr6){#fig6}

###### 

Yeast strains and CBS numbers.

  Strain                                                            CBS no.     No.
  ----------------------------------------------------------------- ----------- -----
  *Candida albicans*                                                CBS 8781    1
  *C. albicans*                                                     CBS 562     2
  *C. albicans*                                                     CBS 8758    3
  *C. albicans*                                                     CBS 1912    4
  *C. albicans*                                                     CBS 2712    5
  *C. albicans*                                                     CBS 5144    6
  *C. dubliniensis*                                                 CBS 8501    7
  *C. dubliniensis*                                                 CBS 8500    8
  *C. glabrata*                                                     CBS 138     9
  *C. glabrata*                                                     CBS 860     10
  *C. guilliermondii*                                               CBS 566     11
  *C. guilliermondii*                                               CBS 2031    12
  *C. krusei*                                                       CBS 573     13
  *C. parapsilosis*                                                 CBS 604     14
  *C. parapsilosis*                                                 CBS 2195    15
  *C. tropicalis*                                                   CBS 94      16
  *C. tropicalis*                                                   CBS 1920    17
  *C. lusitaniae*                                                   CBS 4413    18
  *C. lusitaniae*                                                   CBS 4414    19
  *C. nivariensis*                                                  CBS 9983    20
  *C. nivariensis*                                                  CBS 9985    21
  *C. orthopsilosis*                                                CBS 10741   22
  *C. orthopsilosis*                                                CBS 10906   23
  *C. metapsilosis*                                                 CBS 10746   24
  *C. metapsilosis*                                                 CBS 10747   25
  *Malassezia furfur*                                               CBS 1878    26
  *Cryptococcus neoformans variety grubii* serotype A               CBS 10085   27
  *Cr. neoformans variety grubii* serotype A                        CBS 10083   28
  *Cr. neoformans variety neoformans* serotype D                    CBS 10079   29
  *Cr. neoformans variety neoformans* serotype D (acapsular)        CBS 7935    30
  *Cr. neoformans variety neoformans* serotype AD hybrid            CBS 10080   31
  *Cr. gattii* serotype B                                           CBS 10078   32
  *Cr. gattii* serotype C                                           CBS 10081   33
  *Cr. gattii* serotype B                                           CBS 10082   34
  *Cr. gattii* serotype C                                           CBS 10101   35
  *Cr. gattii* serotype B                                           CBS 11687   36
  *Cr. neoformans* × *Cr. gattii* serotype BD hybrid                CBS 10488   37
  *Cr. neoformans* × *Cr. gattii* serotype AB hybrid                CBS 10496   38
  *Saccharomyces cerevisiae* (virulent)                             CBS 7837    39
  *Saccharomyces cerevisiae* (avirulent, genome sequenced strain)   CBS 8803    40
